In this article, we discuss the 5 healthcare stocks to buy according to John Rogers’ Ariel Investments. If you want to read our detailed analysis of John Rogers’ history, investment philosophy, and hedge fund performance, go directly to the 10 Healthcare Stocks to Buy According to John Rogers’ Ariel Investments.
5. Charles River Laboratories International, Inc. (NYSE:CRL)
Ariel Investments Stake Value: $81.789 million
Percent of Ariel Investments’ Portfolio: 0.76%
Number of Hedge Fund Holders: 44
Charles River Laboratories International, Inc. (NYSE:CRL) is based in Massachusetts and operates an early-stage research company and provides safety testing services in the US and internationally. The company also manufactures clinical equipment.
As of the second quarter of 2021, Ariel Investments holds 221,099 shares of the company worth $81.789 million. Charles River Laboratories International, Inc. (NYSE:CRL) represents 0.76% of John Rogers’ Ariel Investments’ portfolio of 13F securities.
According to the database of Insider Monkey tracking 873 hedge funds in Q2 2021, 44 have stakes in Charles River Laboratories International, Inc. (NYSE:CRL), worth $1.22 billion.
4. Johnson & Johnson (NYSE:JNJ)
Ariel Investments Stake Value: $128.88 million
Percent of Ariel Investments’ Portfolio: 1.21%
Number of Hedge Fund Holders: 88
Johnson & Johnson (NYSE:JNJ), a New Jersey-based company, is engaged in the research and development of drugs and healthcare products. The company has its operations in three segments: consumer health, pharmaceutical, and medical devices.
As of the second quarter of 2021, Ariel Investments holds 782,309 shares of the company, worth $128.88 million. Johnson & Johnson (NYSE:JNJ) represents 1.21% of John Rogers’ Ariel Investments’ portfolio of 13F securities.
3. Gilead Sciences, Inc. (NASDAQ:GILD)
Ariel Investments Stake Value: $172.13 million
Percent of Ariel Investments’ Portfolio: 1.61%
Number of Hedge Fund Holders: 54
Gilead Sciences, Inc. (NASDAQ:GILD) is based in California and operates as drug manufacturer. The company has operations in the US, Europe, and internationally. The company provides drugs for HIV and many other diseases. It has collaboration agreements with companies like Merck and Novo Nordisk.
As of the second quarter of 2021, Ariel Investments holds 2.499 million shares of the company worth $172.14 million. Gilead Sciences, Inc. (NASDAQ:GILD) represents 1.61% of Ariel Investments’ portfolio of 13F securities.
According to the database of Insider Monkey tracking 873 hedge funds in Q2 2021, 54 have stakes in Gilead Sciences, Inc. (NASDAQ:GILD), worth $1.73 billion. This number has decreased from 65 in the Q1 of 2021, worth $2.68 billion.
2. Laboratory Corporation of America Holdings (NYSE:LH)
Ariel Investments Stake Value: $190.3 million
Percent of Ariel Investments’ Portfolio: 1.78%
Number of Hedge Fund Holders: 53
Laboratory Corporation of America Holdings (NYSE:LH) is based in North Carolina and operates as an independent clinical laboratory around the world. The lab operations are divided in two segments: diagnostics and drug development. The company provides specialty testing services.
As of the second quarter of 2021, Ariel Investments holds 689,859 shares in Laboratory Corporation of America Holdings (NYSE:LH), valued at $190.3 million.
According to the database of Insider Monkey tracking 873 hedge funds in Q2 2021, 53 have stakes in Laboratory Corporation of America Holdings (NYSE:LH), worth $2.56 billion. This number has decreased from 54 in the Q1 of 2021, worth $2.47 billion.
1. Envista Holdings Corporation (NYSE:NVST)
Ariel Investments Stake Value: $276.5 million
Percent of Ariel Investments’ Portfolio: 2.59%
Number of Hedge Fund Holders: 38
Envista Holdings Corporation (NYSE:NVST) operates in the healthcare industry with operations in the US and internationally. The company focuses on manufacturing and selling dental products. The company has 30 brands under its name. The company produces and markets dental products and dental equipment.
On September 02, 2021, Credit Suisse adjusted its price target on Envista Holdings Corporation (NYSE:NVST) to $55 and assumed an “Outperform” rating.
At the end of the second quarter of 2021, Ariel Investments held 6.399 million shares worth $276.5 million in Envista Holdings Corporation (NYSE:NVST). The fund reduced its holdings by 5% in the second quarter of 2021.
You can also take a peek at Top 10 Stocks to Buy According to Charles Pollnow’s Triple Frond Partners and 10 Best Safe Dividend Stocks According to Billionaire Dan Loeb.
